In Vitro Inhibition of Cellular Immune Responses by Benzodiazepines and Pk 11195 Effects on Mitogen-and Alloantigen-driven Lymphocyte Proliferation and on IL-1, IL-2 Synthesis and IL-2 Receptor Expression

References

• Tecoma E., Huey L. Psychic distress and the immune response. Life Sci. 1985; 36: 1799
   PubMed Web of Science ®Google Scholar
• Skolnick P., Paul S. M. Molecular pharmacology of the benzodiazepines. Int. Rev. Neurobiol. 1982; 23: 103
   PubMed Web of Science ®Google Scholar
• Marangos P. J., Patel J., Boulenger J. P., Clark-Rosenberg R. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H] Ro 5–4864. Mol. Pharmac 1982; 22: 26
   PubMed Web of Science ®Google Scholar
• Zavala F., Lenfant M. Benzodiazepines and PK 11195 exert im-munomodulating activities by binding on a specific receptor on macrophages. Ann. New York Acad. Sci. 1987; 496: 240
   PubMedGoogle Scholar
• Schlumpf M., Parmar R., Ramseier H, Lichtensteiger W. Prenatal benzodiazepine induced immunosuppression: possible involvement of peripherall benzodiazepine site. Dev. Pharmac. Ther. 1990; 15: 178
   PubMedGoogle Scholar
• Schlumpf M., Pamar R., Ramseier H., Lichtensteiger A. Prenatal benzodiazepine induced immunosuppression: possible involvement of peripheral benzodiazepine sites. Dev. Pharmac. Ther. 1992, in press
   Google Scholar
• Dinarello C. A., Mier J. W. Lymphokines. New Engl. J. Med. 1987; 317: 940
   PubMed Web of Science ®Google Scholar
• Smith K. A. lnterleukin-2: inception, impact, and implications. Science 1988; 240: 1169
   PubMed Web of Science ®Google Scholar
• Balkwill F. R., Burke F. The cytokine network. Immun. Today 1989; 10: 299
   PubMedGoogle Scholar
• Dinarello C. A. lnterleukin-1 and its biologically related cytokines. Adv. Immmun. 1989; 44: 153
   PubMed Web of Science ®Google Scholar
• Munoz E., Beutner U., Zubiaga A., Huber B. IL-1 activates two separate signal transduction pathways in T helper type II cells. J. Immun. 1990; 144: 964
   PubMed Web of Science ®Google Scholar
• Weaver C. T., Unanue E. R. The costimulatory function of antigen-presenting cells. Immun. Today 1990; 11: 49
   PubMedGoogle Scholar
• Swain S. L. Lymphokines and the immune response: the central role of interleukin-2. Curr. Opin. Immun. 1991; 3: 304
   PubMed Web of Science ®Google Scholar
• Smith K. A. The interleukin-2 receptor. Ann. Rev. Cell. Biol. 1989; 5: 397
   PubMedGoogle Scholar
• Click R. E., Benck L., Alter B. J. Immune responses in vitro. Culture conditions for antibody synthesis. Cell. Immunol. 1972; 3: 264
   PubMed Web of Science ®Google Scholar
• Ramseier H. Reconstitution of primary mixed-lymphocyte culture reactions inhibited with class I antibodies by a product of histoincompatible spleen cells. Cell. Immunol. 1987; 110: 95
   Google Scholar
• Kaye J., Porcelli S., Tite J., Jones B., Janeway C. A. Both a monoclonall antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen presenting cells in the activation of T cells. J. Exp. Med. 1983; 158: 836
   PubMed Web of Science ®Google Scholar
• Drach J., Gattringer C., Glassl H., Schwarting R., Stein H., Huber H. Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphoma. Cytometry 1989; 10: 743
   PubMedGoogle Scholar
• Hansen T. H., Spinella D. G., Lee D. R., Shreffler D. C. The im-munogenetics of the mouse histocompatibility complex. Annu. Rev. Genet. 1984; 18: 99
   Google Scholar
• Schlumpf M., Ramseier H., Lichtensteiger W. Prenatal diazepam induced persisting depression of cellular immune responses. Life Sci. 1989; 44: 493
   PubMed Web of Science ®Google Scholar
• Greenblatt D. J., Shader R. I. Benzodiazepines in clinical practice. Raven Press, New York 1974
   Google Scholar
• Rey E., d'Athis Ph., Giraux P., de Lauture D., Turquais J. M., Chavinie J., Olive G. Pharmacokinetics of chlorazepate in pregnant and non-pregnant women. Eur. J. clin. Pharmacol. 1979; 15: 175
   Google Scholar
• Mosmann T. R., Coffman R. L. TH1 and TH2 cells: Different patterns of lympnokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989; 7: 145
   PubMed Web of Science ®Google Scholar
• Coffman R. L., Seymour B. W., Lebman D. A., Hiraki D. D., Christiansen J. A., Shrader B., Cherwinski H. M., Savelkoul H. F.J., Finkelman F. D., Bond M. W., Mosmann T. R. The role of helper T cell products in mouse B cell differentiation and isotope regulation. Immunol. Rev. 1988; 102: 5
   PubMed Web of Science ®Google Scholar
• Stevens T. L., Bossie A., Sanders V. M., Fernadez-Botran R., Coffman R. L., Mosmann T. R, Vitetta E. S. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988; 334: 255
   PubMed Web of Science ®Google Scholar
• Descotes J., Tedone R., Evreux J. C. Suppression of humoral and cellular immunity in normal mice by diazepam. Immunol. Letters 1982; 5: 41
   PubMed Web of Science ®Google Scholar
• Ballantyne D. L, Harper A. D. Prolongation of skin allograft survival by valium (diazepam). Transplant. Proa 1975; 7: 581
   Google Scholar
• Ballantyne D. L., Harper A. D. Prologation of survival in mouse tail skin allografts by valium (diazepam). Transplantation 1977; 23: 163
   Google Scholar
• Laschi A., Descotes J., Tachon P., Evreux J. C. Adverse influence of diazepam upon resistance to Klebsiella pneumoniae infection in mice. Toxicol. Lett. 1983; 16: 281
   PubMed Web of Science ®Google Scholar
• Arora P. K., Hanna E. E., Paul S. M., Skolnick P. Suppression of the immune response by benzodiazepine receptor inverse agonists. J. Neuroimmunol. 1987; 15: 1
   PubMed Web of Science ®Google Scholar
• Richards G., Möhler H., Haefely W. Benzodiazepine receptors and their ligands, in Mechanisms of Drug Action, G. N. Woodruff. MacMillan, London 1986; Vol. 1: 131
   Google Scholar
• Cantrell D. A., Smith K. A. The interleukin 2 T-cell system: a new cell growth model. Science 1984; 224: 1312
   PubMed Web of Science ®Google Scholar
• Covelli V., Decandia P., Altamura M., Jirillo E. Diazepam inhibits phagocytosis and killing exerted by polymorphonuclear cells and monocytes from healthy donors. In vitro studies. Immunopharmacol. Immunotoxicol. 1989; 11: 701
   PubMed Web of Science ®Google Scholar
• Krumholz W., Käbisch S., Biscoping J., Hempelman G. Ueber Veränderung der Adhärenz polymorphkerniger neutrophiler Granulozyten durch die interavenösen Anästhetika Midazolam und Ketamin, Anästh. Intensivther. Notfallmed. 1987; 22: 211
   Google Scholar
• Zavala F., Taupin V., Descamps-Latscha B. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6. J. Pharmacol, exp. Ther. 1990; 255: 442
   PubMed Web of Science ®Google Scholar
• Chang M. P., Castle S. C., Norman D. C. Suppressive effects of alprazolam on the immune response of mice. Int. J. Immunopharmac 1991; 13: 259
   Google Scholar
• Stoeck M., Lees M., Szamel M., Pantaleo G., MacDonald H. R. Comparison of phorbol-12-myristate-13-acetate and diactanoyl-ns-glyc-erol in the activation of EL4/6.1 thymoma cells. J. Cell. Physiol. 1989; 138: 541
   Google Scholar
• Szamei M. M., Kracht B., Krebs B., Hubner U., Resch K. Activation signals in human lymphocytes: interleukin 2 synthesis and expression of high affinity interleukin 2 receptors require differential signalling for the activation of protein kinase C. Cell. Immun. 1990; 126: 117
   Google Scholar
• Neckers L. M., Bauer S., McGlennen R. C., Trepel J. B., Rao K., Greene W. C. Diltiazem inhibits transferrin receptor expression and causes G1 arrest in normal and neoplastic T cells. Mol. Cell Biol. 1986; 6: 4244
   PubMedGoogle Scholar
• Chang M. P., Castle S. C., Norman D. C. Mechanism of immunosuppressive effect of alprazolam: alprazolam suppresses T-cell proliferation by selectively inhibiting the production of IL2 but not acquisition of IL2 receptor. Int. J. Immunopharmac 1992; 14: 227
   PubMedGoogle Scholar